Intratympanic Steroid for the Management of Sudden Hearing Loss: Introduction of a Tapering Method

Document Type : Original

Authors

1 Sinus and Surgical Endoscopic Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Department of Biostatistics, Health School, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction:
Sudden sensorineural hearing loss (SSNHL) is a therapeutic challenge. There are several controversies regarding the management protocol of SSNHL. This study aimed to present the results of a novel treatment algorithm, which is a combination of systemic steroids and a tapering intratympanic (IT) dexamethasone regimen.
Materials and Methods:
The past 10 years’ medical records of idiopathic SSNHL cases in Ghaem and Emamreza hospital, Mashhad University of Medical Sciences were evaluated. Patients were assessed using standardized methods for pure-tone threshold audiometry. The management method of SSNHL treatment included oral steroids combined with IT administration of dexamethasone once a day for 7 days and continuing it on an alternate day and then weekly basis. Patients’ recovery was assessed using Siegel’s criteria.
Results:
This study included a total of 248 cases of idiopathic sudden hearing loss, with a mean age of 40.63±16.19 years. In total, 105 (42.3%) and 143 (57.7%) patients were female and male, respectively. The most common associated symptoms included tinnitus (86.9%, n=205) followed by vertigo (52.1%, n=122). The final hearing outcome of patients showed that 39 (15.7%), 38(15.3%), 86 (34.7%), and 85 (34.3%) patients underwent a complete recovery, partial recovery, slight recovery, and no recovery, based on Siegel’s criteria.
Conclusions:
The dose, interval, and duration of IT steroid treatment were not universally approved. The treatment method designed based on a tapering of IT steroid injection in combination with already known systemic administration of steroids can be a treatment option in SSNHL patients. 

Keywords

References

  1. Vanwijck F, Rogister F, Pierre Barriat S, Camby S, Lefebvre P. Intratympanic steroid therapy for refractory sudden sensory hearing loss: a 12-year experience with the Silverstein catheter. Acta Otolaryngol. 2019;139(2):111-6.
  2. Weiss D, Böcker AJ, Koopmann M, Savvas E, Borowski M, Rudack C. Predictors of hearing recovery in patients with severe sudden sensorineural hearing loss. Journal of Otolaryngology-Head & Neck Surgery. 2017; 46(1): 27.
  3. Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. The Laryngoscope. 2010;120(5):1011-21.
  4. Pitaro J, Bechor-Fellner A, Gavriel H, Marom T, Eviatar E. Sudden sensorineural hearing loss in children: Etiology, management, and outcome. International journal of pediatric otorhinolaryngology. 2016;82:34-7.
  5. Hobson CE, Alexander TH, Harris JP. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone. Current opinion in otolaryngology & head and neck surgery. 2016;24(5):407-12.
  6. Berjis N, Soheilipour S, Musavi A, Hashemi SM. Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss. Advanced biomedical research. 2016;5.
  7. Chen S, Zhao M, Qiu J. Acupuncture for the treatment of sudden sensorineural hearing loss: A systematic review and meta-analysis: Acupuncture for SSNHL. Complementary therapies in medicine. 2019;42:381-8.
  8. Dinç ASK, Çayönü M, Boynueğri S, Tuna EÜ, Eryılmaz A. Is Salvage Hyperbaric Oxygen Therapy Effective for Sudden Sensorineural Hearing Loss in Patients with Non-response to Corticostreoid Treatment? Cureus. 2020;12(1).
  9. Attanasio G, Russo F, Di Porto E, Cagnoni L, Masci E, Ralli M, et al. Prediction of hearing recovery in sudden deafness treated with intratympanic steroids. Acta Otorhinolaryngologica Italica. 2018; 38(5): 453.
  10. Schwartz SR, Zeitler D. Clinical Practice Guideline: Sudden Hearing Loss (Update) for Audiology. The Hearing Journal. 2019;72(12):34-5.
  11. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otology & Neurotology. 2005; 26(5): 878-81.
  12. Kang WS, Yang CJ, Shim M, Song CI, Kim TS, Lim HW, et al. Prognostic factors for recovery from sudden sensorineural hearing loss: a retrospective study. Journal of audiology & otology. 2017; 21(1):9.
  13. Cheng Y-F, Chu Y-C, Tu T-Y, Shiao A-S, Wu S-L, Liao W-H. Modified Siegel's criteria for sudden sensorineural hearing loss: Reporting recovery outcomes with matched pretreatment hearing grades. Journal of the Chinese Medical Association. 2018;81(11):1008-12.
  14. Olusanya BO, Davis AC, Hoffman HJ. Hearing loss grades and the International classification of functioning, disability and health. Bulletin of the World Health Organization. 2019;97(10):725.
  15. Ermutlu G, Süslü N, Yılmaz T, Saraç S. Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments. European Archives of Oto-Rhino-Laryngology. 2017;274(10):3585-91.
  16. Cassandro C, De Luca P, Ralli M, Gioacchini F, Di Berardino F, Albera A, et al. Recurrence of Non-Hydropic Sudden Sensorineural Hearing Loss (SSNHL): A Literature Review. Translational Medicine@ UniSa. 2019;20:22.
  17. Khamvongsa P, Patel N, Ali AA, Bodoukhin N, Carreno O. Using corticosteroids to treat sudden sensorineural hearing loss in pregnancy: A case report and literature review. Case Reports in Women's Health. 2020:e00201.
  18. Mirian C, Ovesen T. Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngology–Head & Neck Surgery. 2020.
  19. Kosyakov S, Atanesyan A, Gunenkov A, Ashkhatunyan E, Kurlova A. Intratympanic steroids for sudden sensorineural hearing loss. Int Adv Otol. 2011;7:323-32.
  20. Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngology—Head and Neck Surgery. 2001;125(3):142-6.
  21. Ashtiani MK, Firouzi F, Bastaninejad S, Dabiri S, Nasirmohtaram S, Saeedi N, et al. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial. European Archives of Oto-Rhino-Laryngology. 2018; 275(1):89-97.
  22. Kosyakov S, Atanesyan A, Gunenkov A, Ashkhatunyan E, Kurlova A. Intratympanic steroids for sudden sensorineural hearing loss. J Int Adv Otol. 2011;7(3):323.
  23. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone+ high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otology & Neurotology. 2008;29(4):453-60.
  24. Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. Jama. 2011;305(20):2071-9.
  25. Hong SM, Park CH, Lee JH. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngology--Head and Neck Surgery. 2009; 141(5):579-83.
  26. Lai D, Zhao F, Jalal N, Zheng Y. Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials. Medicine. 2017;96(50).
  27. Chiossoine-Kerdel JA, Baguley DM, Stoddart RL, Moffat DA. An investigation of the audiologic handicap associated with unilateral sudden sensorineural hearing loss. Otology & Neurotology. 2000;21(5):645-51.
  28. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otology & Neurotology. 2012;33(4):523-31.
  29. Si Y, Jiang HL, Chen YB, Chu YG, Chen SJ, Chen XM, et al. Round window niche drilling with intratympanic steroid is a salvage therapy of sudden hearing loss. Audiology and Neurotology. 2018; 23(6):309-15.
  30. Mühlmeier G, Baguley D, Cox T, Suckfüll M, tinnitus related to idiopathic sudden sensorineural hearing loss. Otology & Neurotology. 2016; 37(6):634.
  31. Elayoubi S-E, Salahaldin L, Chahed T, editors. Admission control-based pricing in UMTS. Proceedings 2004 International Conference on Information and Communication Technologies: From Theory to Applications, 2004; 2004: IEEE.
  32. Ben-David J, Luntz M, Magamsa I, Fradis M, Sabo E, Podoshin L. Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss. The international tinnitus journal. 2001;7(1):62-4.
  33. LIAN H, Idrus RB, Saim LB, Saim AB. Intratympanic Methylprednisolone Injection in Idiopathic Sudden Sensorineural Hearing Loss after Failure of Systemic Corticosteroid Therapy. Sains Malaysiana. 2018;47(11):2777-82.

 

  1. Deenadayal D, Vidyasagar D, Bommakanti V, Goel K, Naeem N. Role of Intratympanic Steroids in the Management of Meniere’s Disease—A Review of 151 Cases. International Journal of Otolaryngology and Head & Neck Surgery. 2016; 5(2):108-13.
  2. Choi SJ, Lee JB, Lim HJ, In SM, Kim JY, Bae KH, et al. Intratympanic dexamethasone injection for refractory tinnitus: Prospective placebo‐controlled study. The Laryngoscope. 2013;123(11):2817-22.
  3. Shim HJ. Intratympanic steroid injection in tinnitus management. Hanyang Medical Reviews. 2016;36(2):125-30.
Iranian Journal of Otorhinolaryngology
Volume 34, Issue 1
January and February 2022
Pages 9-16

Files

Share

How to cite

Statistics